Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14835389Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Linked Award Amount
$217K
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#45,026
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Ashley Levack as a PI. Multi-PI records show the full award amount for context.
- 1R21AR084183-01R21The utility of bacteriophage therapy in fracture-related infections: Preclinical research needed to create effective and reproducible treatment protocols$217Kaward amount
Award organization
Organizations that administered FY2024 awards listing Ashley Levack as a PI.
FY2024 award administered by Loyola University Chicago (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardLoyola University Chicago
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Ashley Levack.